VGTI Florida, The Vaccine & Gene Therapy Institute of Florida, Port St. Lucie
Budget: ~$48.6 million.
Size: 100,000 ft2.
Project team: Mann Research Center LLC, Port St. Lucie, Florida (developer); HOK Architects Inc., Tampa, Fla. and Atlanta (architect); ARC3 Architects, St. Petersburg, Fla. (architect); Affiliated Engineers Inc., Gainesville, Fla. (MEP engineer); EDC Corp., Miami (civil engineer); Camarda Development Group, Port St. Lucie, Fla. (project management); Facility Logix, LLC, Burtonsville, Md. (laboratory project management); Coutler & Hearing, Jupiter, Florida (landscape architect), Cornerstone Commissioning, Boxford, Mass. (commissioning); The Whiting-Turner Contracting Co., Orlando/Tampa (general contractor)
Completion date: 1Q2012.
Description: VGTI Florida's new research and development facility boasts nine major laboratories where scientists will conduct research to identify treatments and therapies to help the human immune system fight cancer, infectious and chronic diseases like HIV/AIDS, and arthritis. The research facility includes a small mammal vivarium housing mice and rabbits. VGTI Florida scientists are taking basic and clinical science from laboratory bench to bedside, to help change the lives of millions susceptible to or afflicted with the world's most devastating "incurable" diseases. The facility includes an ABSL-3 component as well as BSL-3 laboratories. The project adds to the critical mass of new research institutes and clinical capabilities at the Tradition Center for Innovation, joining the Torrey Pines Institute for Molecular Science, the Mann Research Center and the soon to be built Martin Health System's Tradition Medical Center. The project is pursuing LEED certification. Funding support was provided by the U.S. Economic Development Association, the city of Port St. Lucie, Port St. Lucie County, and the state of Florida.
Contact: Patricia L. Larrabee, Facility Logix LLC, firstname.lastname@example.org